Catalyst Wire Dossier Catalyst Wire Dossier

YL205

· MediLink Therapeutics (Suzhou) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YL205, covering 2025-12-23 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of YL205 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing